Support provided by independent educational grants from Astellas, Bayer HealthCare Pharmaceuticals Inc., Genentech, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC., Merck and Pfizer, Inc.

CME Available: auau.auanet.org/node/31819

At the conclusion of this educational series, participants will be able to:

1. Discuss the impact of SDM on patients and on patient-clinician communication.

2. Identify at least one implementation strategy for using SDM in clinical practice.

3. Apply SDM techniques in a role-playing exercise with other colleagues.

4. Incorporate culturally sensitive communications to ensure quality SDM and reduce biases.

5. Utilize the knowledge and experience they have gained through role-play into their routine practice-counseling patients.